Drug Design, Development and Therapy (Mar 2011)

Corrigendum

  • Channing J Paller,
  • Emmanuel S Antonarakis

Journal volume & issue
Vol. 2011, no. default
pp. 183 – 184

Abstract

Read online

Paller CJ, Antonarakis ES. Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer.Drug Design, Development and Therapy. 2011;5:117–124. The drug Jevtana was incorrectly named Jentava in Table 4.Original Article